What We're Reading: Page 275
Industry reads hand-picked by our editors
Mar 16, 2018
-
The Economist
Which firms profit most from America's health-care system
-
Bloomberg
Pfizer lifts CEO's pay 61% to $27.9 million with retention bonus
-
The Diplomat
China prepares for big pharma
Mar 15, 2018
Mar 14, 2018
Mar 13, 2018
Mar 12, 2018
-
TechCrunch
Corporate bio VCs are backing more rounds and making bigger bets
-
Xconomy
Despite pharma ties, some patient groups protest high drug prices
-
The New York Times
Ask your doctor. Until then, here’s a word from our sitcom.
-
The Wall Street Journal
Cures welcome at FDA
Mar 09, 2018
-
The New York Times
Merck C.E.O. Ken Frazier on death row cases and the corporate soul
-
CNBC
The quest for the blockbuster Alzheimer’s drug has stalled, but there's another option
-
Boston Business Journal
Under SEC scrutiny, Bedford’s Ocular Therapeutix plans FDA do-over
-
Bloomberg
Diabetes drug developer Hua picks Hong Kong for IPO
Mar 08, 2018
-
Bloomberg BNA
Pharma class is in session more and more
-
Reuters
Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage
-
CNN
Cancer treatment guidelines questioned in new study
-
Xconomy
Prevail gets $75M for Parkinson’s gene therapy, bolstering NY biotech
-
Associated Press
FDA did not issue new statement on vaccines and autism
Previous
